Pharma layoffs in 2023: Companies making cuts

[Image courtesy of Adobe Stock]

A recession in 2023 is highly probable. Some two-thirds of economists surveyed at the World Economic Forum in Davos said they anticipated an economic downturn this year. 

Given the difficult economic situation, a growing number of pharmaceutical firms are reducing staff. Several companies announced cuts at the end of 2022, including Catalent and Novartis. 

The following is a list of some significant pharma layoffs announced at the outset of 2023.

Amgen cuts 300 workers 

The company is undergoing a restructuring effort that includes layoffs of around 300 employees. The pharma layoffs will primarily affect employees in the commercial team based in the U.S., according to a report obtained from Endpoints. 

Merck KGaA lays off 133

Merck KGaA, Darmstadt, Germany, is letting go of 133 jobs in Billerica, Massachusetts, as part of a restructuring effort, according t…

Read more
  • 0